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ABSTRACT
Objective: To revise the national HIV estimates and
quantify the magnitude of the HIV epidemic in Ukraine at
the end of 2007.
Design: Internationally recommended methods—the
Workbook and Spectrum—were employed to generate
the estimates. This enables comparison of results with
other countries using the same methodology.
Methods: Estimation of the size of most at-risk
populations nationally was performed using capture-
recapture, multiplier and triangulation methods. HIV
prevalence among most at-risk populations was esti-
mated by linked HIV sentinel and behavioural surveillance
among injecting drug users, and men who have sex with
men, and unlinked sentinel surveillance among sex
workers. The range of HIV prevalence and extrapolation
for populations at lower risk were determined by
consensus among national stakeholders. Results were
reviewed by national stakeholders and endorsed by the
government of Ukraine.
Results: At the end of 2007, an estimated 395 000
adults (range 230 000–573 000) aged 15–49 were living
with HIV in Ukraine. Adult HIV prevalence was estimated
at 1.63%, which represents the highest adult HIV
prevalence of any country in Europe.
Conclusions: The HIV epidemic in Ukraine
continues to grow at a record pace, concentrated
among most at-risk populations, the majority of whom are
unaware of their HIV status. The results emphasise the
need to accelerate the coverage and quality of prevention
programmes among most at-risk populations and their
sexual partners.
The HIV epidemic in Ukraine remains concen-
trated among most-at-risk populations (MARPs),
including injecting drug users (IDUs), sex workers
(SWs), men who have sex with men (MSM) and
sexual partners of these populations. Twenty years
since its establishment, the national surveillance
system for HIV infection continues to be based on
HIV case reporting. This surveillance system has
been more successful at identifying HIV infection
among IDUs than SWs and MSM.
1 Sentinel
surveillance among MARPs has indicated further
under-reporting of officially registered cases of HIV
infection among these populations, with a number
of regions reporting consistently high prevalence
rates in some of these groups.
The previous HIV/AIDS estimates in Ukraine
(2006),
2 based on the best data available at the
time, indicated 377 600 people living with HIV
infection in Ukraine at the end of 2005. These
estimates included 344 000 people living with HIV
aged 15–49, representing 1.46% of the adult
population of Ukraine.
Since 2005 the HIV epidemic in Ukraine has
continued to grow. As of the end of 2007, over
122 500 people had been officially registered with
HIV infection since the HIV surveillance began in
1987. In 2007, a record number of newly diagnosed
individuals with HIV infection were reported—
17 699—or an increase of 10% from 2006. Clinical
progression from HIV infection to AIDS and death
is occurring with greater frequency in Ukraine. At
the end of 2007, 22 424 people had been diagnosed
with AIDS since the beginning of the epidemic,
including 12 490 who had died of AIDS. The
number of reported AIDS cases includes 4573
people who were newly diagnosed with AIDS in
2007, a slight decrease of 3.2% from the previous
year. AIDS mortality also increased over time, with
2507 AIDS-related deaths reported in 2007.
1
These officially reported data underestimate the
scale of the HIV epidemic in Ukraine as they
provide information only about individuals who
have been tested, diagnosed with HIV and included
into the official national registry. With an inde-
terminate proportion of the population unaware
that they are infected with HIV, it was important
to develop up-to-date and accurate estimates of the
magnitude of the HIV epidemic in Ukraine. These
estimates were also essential to improve access to
voluntary counselling and testing (VCT) services
for the general population as well as for MARPs.
In 2007 the Ukrainian AIDS Centre under the
Ministry of Health decided to revise its national
estimates for HIV/AIDS by using the Workbook
and Spectrum tools, based on the recommenda-
tions of the Joint United Nations Programme on
HIV/AIDS (UNAIDS) Reference Group on
Estimates, Modelling and Projections.
3 The 2007
estimates were developed in Kyiv (Kiev) by a
national working group led by the Ukrainian AIDS
centre, with technical support provided by the
World Health Organization and UNAIDS, and in
partnership with the International HIV/AIDS
Alliance and other organisations. The estimates
were subsequently reviewed by national stake-
holders, and then endorsed by the Ministry of
Health. The estimates also drew on the results of
recent research into the size of MARPs and their
behaviours. This paper describes the methods and
sources of data, as well as the results of these
estimates and their significance for Ukraine’s
response to the HIV epidemic.
METHODS
In late 2007 the national working group conducted
a series of technical meetings to review the process
for generating new estimates and the data needs.
In order to be consistent with the methodology
Supplement
Sex Transm Infect 2008;84(Suppl I):i37–i41. doi:10.1136/sti.2008.031195 i37used for generating previous estimates for 2005, the national
working group agreed to use Workbook and Spectrum.
The working group selected the Workbook Method A as the
most appropriate for Ukraine, allowing for estimates to be based
on MARPs and their sexual partners. The most recent data
among antenatal clinic attendees indicate that HIV prevalence
among pregnant women is increasing, from 0.45% in 2005 to
0.52% in 2007, but remains significantly lower than among
MARPs. Estimates based on antenatal care data (Workbook
Method B) would have risked a significant underestimation of
the magnitude of the epidemic, which remains concentrated
among MARPs.
The key data requirements for Method A in Workbook were
up-to-date and reliable estimates of the size of and HIV
prevalence among IDUs, SWs and MSM, and their sexual
partners. For each of these MARPs, high and low estimates were
made for the population size, based on the most recent research
4
conducted in 2004–5, which were also used to generate the
previous estimates in 2005. The methods for estimating the size
of these populations were consistent with international
recommendations, based on a combination of capture-recap-
ture, multiplier and triangulation methods.
45While there might
have been minor fluctuations in the size of some of these
populations since 2005, it was agreed that the extent of these
changes were not believed to undermine the reliability of the
existing data.
In many cases, the research also generated disaggregated data
for the size of these populations at the regional level. Owing to
the limitations of the research design, it was determined that
the accuracy of the population estimates for specific regions was
limited, and thus only the aggregated national estimates would
be used for the development of new national estimates. For the
purpose of simplicity and operational ease, the figures were
rounded to the closest thousandth.
The following data were used as inputs for 2007 estimates
into Workbook on the size of MARPs and the HIV prevalence
rates among these groups.
Estimation of size of populations at higher risk (PHR)
c Estimated number of IDUs: from 325 000 to 425 000. In
Ukraine, there are also frequent occurrences of injecting
drug use among SWs. The estimated numbers of IDUs
include SWs who are also engaged in injecting drug use, who
otherwise were not included in the estimated number of
SWs, as injecting drug use was considered to be a higher
behavioural risk for HIV. Thus, overlap between such
populations in these estimates was avoided.
c Estimated number of SWs: from 110 000 to 250 000. This
estimate includes only female SWs, as the group of male
SWs is believed to be smaller and harder to reach than
female SWs. Only street-based SWs who could be reached
by current prevention programmes and HIV surveillance
studies were included in the estimates.
c Estimated number of MSM: from 177 000 to 430 000. The low
population estimate was generated by triangulation
research, whereas the high estimate was based on the
internationally recognised conservative estimate of the
percentage of the male population that practises sex with
men—3% of the adult male population.
c Estimated number of clients of SWs: from 330 000 to 750 000.
No specialised research has been conducted in Ukraine to
estimate the size of this specific population, so it was agreed
to use the average number of clients reported by SWs per
week, which ranged from two to six.
6 The average of three
clients per SW, per week, was used to calculate the number
and range of male clients. There remain concerns that these
figures may underestimate the number of clients of SWs,
but no other data are currently available.
c Number of prisoners: 130 000. It was also agreed to add
prisoners as an additional MARP, as the size of this
population and data on HIV prevalence are available and
of high quality. The addition of prisoners was not meant to
indicate that imprisonment is considered to be a risk factor
for HIV infection. Instead, it is suspected that there is a high
prevalence of injecting drug use and a high proportion of
MSM among prisoners. The sizes of the groups of IDUs or
M S Mw h om a yb ei np r i s o nw e r ei n c l u d e di nt h e
calculations for prisoners, as they were not included in the
estimates of other MARPs.
Estimation of size of populations at lower risk (PLR)
In addition to the size of MARPs, the Workbook methodology
also requires estimates on the size of so-called ‘‘bridge
populations’’ that are at lower risk for HIV. Specific research
has not been conducted in Ukraine to develop reliable estimates
of the size and HIV prevalence for these groups. It was agreed
that the size estimates for these groups would be based on
relevant data drawn from recent behavioural studies among
MARPs and informed by the opinions of national and
international experts, with all assumptions about HIV pre-
valence being made explicit for each of the bridge populations.
6–9
c Estimated number of sexual partners of IDUs: The number of
sexual partners of IDUs was calculated on the basis of
results of a special survey on IDU behaviour which indicated
that an IDU had on average between one and three sexual
partners.
7 The coefficient of 1.3 sexual partners per IDU was
applied to estimate the number of sexual partners of IDUs.
The final range used for the national estimations was from
422 500 to 552 500 sexual partners of IDUs.
c Estimated number of female partners of MSM: The number of
female partners of MSM was calculated on the basis of
results of a special survey on MSM behaviour,
8 which
indicated that 33% of MSM had an average of three female
sexual partners. The coefficient of one female sexual partner
per MSM was applied to an estimated number of female
sexual partners of MSM. The final range used for the
national estimations was from 177 000 to 430 000 female
partners of MSM.
c Estimated number of sexual partners of clients of SWs: The
number of sexual partners of clients of SWs was calculated
on the basis of the preliminary research into behaviours
among bridge populations (International HIV/AIDS
Alliance in Ukraine, Report on Bridge Populations, Kyiv,
2006, unpublished), which indicated that each client had an
average of an additional 2.5 non-commercial sexual partners.
The coefficient of 2.5 sexual partners per SW client was
applied to the estimated number of sexual partners of SW
clients. The final range used was from 825 000 to 1 875 000
sexual partners of clients of SWs. It was assumed that all of
the sexual partners of the clients of female SWs were female.
HIV prevalence data for 2007 estimates
In 2007, the Ukrainian AIDS Centre conducted a linked HIV
biological and behavioural surveillance survey in different cities
of Ukraine to determine the HIV prevalence among IDUs in six
sites and MSM in four sites using respondent driven sampling
(RDS).
1 The HIV prevalence ranged from 10.4% (city of
Lugansk) to 87.8% (city of Krivoy Rog) among IDUs, and from
4.4% (city of Kyiv) to 23.2% (city of Odessa) among MSM.
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RDS tools provided a range that eliminated the outlier values.
For the IDU data entry into Workbook, it was agreed to use the
prevalence range of 17.3% to 70%. Given the small number of
sentinel sites for MSM, it was agreed not to eliminate the
outlier values and for the data entry into Workbook to use
rounded prevalence values of 4% to 23%.
The most recent data on HIV prevalence among non-IDU
SWs was collected in 2007, through unlinked biological sentinel
surveillance in nine sites, with a range of HIV prevalence from
4% (city of Kyiv) to 31% (city of Poltava). It was agreed to
eliminate the outlier values and to use the prevalence range of
8% to 30% for the data entry into Workbook.
For prisoners, the HIV prevalence data were based on the
latest results of HIV surveillance from the state prison
department, with the low prevalence taken from the lower
range of the results of regular surveillance among prisoners, and
the high prevalence taken from the upper range of results from
sentinel surveillance in selected prisons (unpublished data from
the state prison department, 2007).
For the population of male clients of FSWs and the other
populations at lower risk, there is no sentinel surveillance data
available in Ukraine. Therefore, the working group used best
estimates of the likely HIV prevalence rates, with the range
being linked, but consistently lower than the range of HIV
prevalence among the populations at higher risk.
As Ukraine is a country with a concentrated HIV epidemic
among specific MARPs, existing estimates of the size of
populations at higher and lower risk, as well as data on HIV
prevalence in these groups, were entered into the Workbook
spreadsheet model
9 to develop the point prevalence among
adults in Ukraine as of the end of 2007. The final sets of inputs
for Workbook are presented in table 1.
The HIV point prevalences for 2003 and 2005 were based on
the results of the previous national HIV estimates generated by
Workbook, 1.08% and 1.46%, respectively. However, the data
required to generate estimates for previous years were not
available. In order to develop data for the missing HIV point
prevalence rates, it was assumed that in previous years, the
national HIV-prevalence rate was 1.5 times higher than the
officially reported number of registered cases of HIV. This
coefficient of 1.5 was used to multiply the number of officially
registered cases for the earlier years of the epidemic. For interval
years where no estimates were generated, the HIV point
prevalence was calculated as the average between the two
existing prevalence points, thus providing a complete point
prevalence curve for each year since 1991 (fig 1).
The Workbook outputs with the point prevalence were
entered into the Spectrum Policy Modelling System
(Spectrum).
10 Spectrum was used to generate detailed estimates
for HIV and AIDS for Ukraine as of the end of 2007, and
projections for the period up to 2013. Inputs were made to the
‘‘Epidemiology’’ section under the AIDS (AIM) module in
Spectrum. The HIV prevalence curve was imported from the
Workbook file into Spectrum with the following values (table 2).
The following assumptions were made for the other
Spectrum inputs:
c The percentage of all pregnant women receiving prevention
of mother-to-child (PMTCT) services was 86% in 2003, with
a gradual increase to 93% over the period of 2004–10. The
rate of mother-to-child transmission in the absence of the
PMTCT programme was 32% (before 2003) and 10%, which
is based on a combination of zidovudine (AZT) and single-
dose nevirapine.
c The percentage of those on antiretroviral treatment (ART)
surviving to the following year was assumed to be 85%.
c The ‘‘regular progression’’ model of HIV progression was
used as the variable for the speed of HIV progression.
Using Spectrum, these same data were used to determine the
range of these estimates. Using the uncertainty analysis
function, Spectrum generated the ranges for the adult HIV
prevalence based on plausibility bounds of 95%.
The outputs from Workbook and Spectrum were reviewed
and revised during a series of meetings by the working group
before they were finalised in January 2008. The final step in the
process was the review of the new estimates at a public meeting
of the stakeholders, chaired by the Minister of Health of
Figure 1 HIV point prevalence curve in Ukraine, 1987–2007.
Table 1 Estimated population size and HIV prevalence rates among populations at higher and lower risk,
Ukraine, end of 2007
Population groups
Population size estimate HIV prevalence estimate
Low estimate High estimate Low High
Populations at higher risk:
IDUs 325 000 425 000 17.30% 70.00%
MSM 177 000 430 000 4.00% 23.00%
SWs (female) 110 000 250 000 8.00% 30.00%
Male clients of SWs 330 000 750 000 2.00% 5.00%
Prisoners 130 000 130 000 3.50% 12.0%
Populations at lower risk that are not included in
PHR:
Partners of IDU 422 500 552 500 8.00% 30.00%
Female partners of MSM 177 000 430 000 1.30% 7.60%
Partners of clients of SWs 825 000 1 875 000 1.16% 2.00%
IDUs, injecting drug users; MSM, men who have sex with men; SWs, sex workers; PHR, populations at higher risk.
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Ukraine’s 2008 Report on Monitoring Progress towards the
UNGASS Declaration of Commitment on HIV/AIDS.
RESULTS
The results from Workbook indicate that at the end of 2007,
there were an estimated 395 296 adults (aged 15–49) living with
HIV in Ukraine (table 3). The adult HIV prevalence was
estimated at 1.63%, which represents the highest adult HIV
prevalence of any country in Europe. Based on the uncertainty
analysis generated by Spectrum, the range for the adult HIV
prevalence was between 0.95% and 2.37%—equal to 230 000–
573 000 adults (15–49) living with HIV.
The results from Workbook indicate that 163 688 IDUs are
estimated to be living with HIV, representing 41.4% of all adults
living with HIV. This indicates that between 38.5% and 50.3%
of the estimated population of IDUs are already infected with
HIV. The proportion of IDUs among adults living with HIV is
closely correlated with the official surveillance data which
estimates 40% of newly reported cases of HIV in 2007 being
attributed to IDUs.
Among SWs, the estimated HIV prevalence is high, ranging
from 13.6% to 31.0% of the estimated SW population. The data
also indicate that 10.0% to 23.0% of the estimated population of
MSM are currently living with HIV.
These results indicate that the gap is narrowing between the
number of adult men and women with HIV, with women
representing 45% of the adults living with HIV. These data are
largely consistent with the officially reported ratio between
men and women, with women accounting for 43.8% of all the
newly registered cases of HIV in 2007.
Spectrum also enabled us to expand the estimates for the
entire population, indicating the overall HIV prevalence of
1.08%. These data from Spectrum indicate an additional 44 585
people living with HIV outside the age range of 15–49 years.
Thus, a total of 439 881 people were estimated to be living with
HIV in Ukraine, including 251 330 males and 188 551 females.
However, the working group agreed to use the prevalence figure
of 1.63% as the official estimates for 2007, as this figure is based
on the estimated adult prevalence for the age group 15–49, and
thus can be compared to other countries using the same
methodology.
DISCUSSION
The most sobering conclusion that can be drawn from the 2007
estimates is that the HIV epidemic in Ukraine continues to
grow at a record pace. With a high and growing adult HIV
prevalence, Ukraine maintains its unfortunate distinction of
having the highest HIV prevalence of any country in Europe. In
comparison to the previous 2005 estimates, the 2007 estimates
indicate the epidemic continues to spread, mainly among
MARPs, many of whom remain unaware of their HIV status.
This has serious implications for prevention programmes among
these groups. These programmes need to focus more on VCT
and behaviour change, as well as providing access to care,
treatment and support services.
The 2007 estimates reflect the opinions among an extensive
range of national and international experts who participated in
the process of generating these estimates. These estimates are
considered valid and currently represent the most accurate and
comprehensive HIV estimates available for Ukraine at the end
of 2007. Key information, particularly information on size of
the populations such as sexual partners of the MARPs and HIV
prevalence data among these groups, is still lacking. For these
reasons, these estimates should be cited and used with a degree
of caution until more relevant data become available. In
particular, the use of the Workbook method is highly sensitive
to the results of sentinel surveillance data from MARPs, which
are extremely high in Ukraine. The authors acknowledge that
the transposition of the sentinel surveillance data may have
resulted in some degree of overestimation of national HIV
prevalence. In order to minimise such risks, the authors propose
to pilot the use of the Estimations and Projection Package (EPP)
to generate and compare future national HIV estimates.
The process of developing these estimates underscores the
importance of generating a national consensus on the status of
the HIV epidemic. As a result of extensive consultations and the
strategic dissemination of the results, national stakeholders,
including high-level decision-makers such as the President of
Ukraine and the Minister of Health, have accurately cited these
estimates. The estimates depict the magnitude of the epidemic,
and provide a robust epidemiological baseline for the develop-
ment of a new national AIDS programme in Ukraine for the
next five years.
Table 2 Point prevalence of HIV infection by years,
Ukraine, 1990–2007
Year HIV point prevalence
1990 0.00%
1991 0.01%
1992 0.01%
1993 0.01%
1994 0.01%
1995 0.03%
1996 0.14%
1997 0.33%
1998 0.49%
1999 0.59%
2000 0.68%
2001 0.79%
2002 0.93%
2003 1.08%
2004 1.26%
2005 1.46%
2007 1.63%
Table 3 Estimated number of people living with HIV by groups of the
populations at higher and lower risk, and estimated adult HIV prevalence,
Ukraine, end of 2007
Population group Number
IDUs 164 000
MSM 41 000
FSWs 34 000
Male clients of FSWs 19 000
Prisoners 10 000
Subtotal PHR 268 000
Partners of IDU 93 000
Female partners of MSM 13 500
Partners of clients of FSWs 21 000
Subtotal PLR 127 000
Total number of adults (15–49) living with HIV 395 000
Number of women (15–49) living with HIV 178 000
Percentage of people living with HIV who are female 45.0%
Percentage of total people living with HIV that are IDU 41.4%
Percentage of adult (aged 15–49) prevalence 1.63%
IDUs, injecting drug users; MSM, men who have sex with men; FSWs, female sex
workers; PHR, populations at higher risk; PLR, populations at lower risk.
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